We show that expression of one of these enzymes—the glutamate‐cystine antiporter SLC7A11, up‐regulated 6‐fold in a cisplatin‐resistant lung cancer cell line—has potential prognostic significance in lung cancer but not ovarian cancer. Here, SLC7A11 is linked to ovarian cancer.